{
  "docId": "019de074-1527-7308-955d-4c9eab2bbacb",
  "docSlug": "e812f3c221148b99b15c4527dea8f94b",
  "documentTitle": "argenx SE | Results Presentation Deck | 15 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 15,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 30,
  "notes": "The table compares adverse events (TEAEs) and specific common events between treatment and placebo groups.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-1527-7308-955d-4c9eab2bbacb/13",
  "deckHref": "/decks/019de074-1527-7308-955d-4c9eab2bbacb",
  "deckJsonHref": "/decks/019de074-1527-7308-955d-4c9eab2bbacb.json",
  "deckAnchorHref": "/decks/019de074-1527-7308-955d-4c9eab2bbacb#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.11,
        "y": 0.93
      },
      "kind": "disclaimer",
      "text": "AESI = adverse event of special interest (defined per protocol); ITP = immune thrombocytopenia; PI = principal investigator; TEAE = treatment-emergent adverse event.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7dc25912-9380-4b3b-b20b-2823bcdb6c85",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.78,
        "x": 0.11,
        "y": 0.2
      },
      "kind": "table",
      "text": "Comparison of TEAEs and common adverse events between Efgartigimod (n=86) and Placebo (n=45)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc996d14-7bc6-4501-ad69-927a6c883fce",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.09,
        "y": 0.05
      },
      "kind": "title",
      "text": "Efgartigimod Was Well-Tolerated in Patients With ITP and Consistent With Other Efgartigimod Studies1-5",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a079dd55-42f2-486e-9d07-57d2e3891f9a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}